Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals ; volume:8 ; number:1 ; day:9 ; month:10 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (9.10.2018), 1-10, 12.2018
- Creator
-
Mesquita, Emersom C.
- Contributor
-
Hottz, Eugenio D.
Amancio, Rodrigo T.
Carneiro, Alan B.
Palhinha, Lohanna
Coelho, Lara E.
Grinsztejn, Beatriz
Zimmerman, Guy A.
Rondina, Matthew T.
Weyrich, Andrew S.
Bozza, Patrícia T.
Bozza, Fernando A.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-33403-0
- URN
-
urn:nbn:de:101:1-2018111222491296605489
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mesquita, Emersom C.
- Hottz, Eugenio D.
- Amancio, Rodrigo T.
- Carneiro, Alan B.
- Palhinha, Lohanna
- Coelho, Lara E.
- Grinsztejn, Beatriz
- Zimmerman, Guy A.
- Rondina, Matthew T.
- Weyrich, Andrew S.
- Bozza, Patrícia T.
- Bozza, Fernando A.
- SpringerLink (Online service)
Other Objects (12)
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
HCV coinfection aggravated the decrease of platelet counts, but not mean platelet volume in chronic HIV-infected patients
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
Platelet activation in adult HIV-infected patients on antiretroviral therapy: a systematic review and meta-analysis
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort
Hepatitis B coinfection in HIV-infected patients
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
HCV coinfection aggravated the decrease of platelet counts, but not mean platelet volume in chronic HIV-infected patients
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
Platelet activation in adult HIV-infected patients on antiretroviral therapy: a systematic review and meta-analysis
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort
Hepatitis B coinfection in HIV-infected patients
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
HCV coinfection aggravated the decrease of platelet counts, but not mean platelet volume in chronic HIV-infected patients
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
Platelet activation in adult HIV-infected patients on antiretroviral therapy: a systematic review and meta-analysis
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort